RxDoctor Payments Data

Lisa Buell, MD

Family Medicine · Fort Worth, TXNPI 1689660557

Payments from drug & device makers

$11,928in general payments, 2019–2025

Across 796 payments — averaging $14.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$1K
  • Novo Nordisk$1K
  • Amarin Pharma, Inc.$862
  • Amgen$805
  • Boehringer Ingelheim$779
  • plus $6K from 54 others

What the payments were for

  • Food & beverage$11,872100%
  • Education$420%
  • Entertainment$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)116$1,660
AstraZeneca57$1,034
Novo Nordisk76$1,027
Amarin Pharma, Inc.69$862
Amgen(2 entities)51$805
Boehringer Ingelheim51$779
Lilly USA, LLC48$740
Pfizer50$537
Astellas Pharma US Inc29$475
Merck24$318
Takeda Pharmaceuticals U.S.A., Inc.24$310
GSK17$295
Abbott13$272
Otsuka America Pharmaceutical, Inc.16$266
Biohaven Pharmaceuticals, Inc.11$138
Bayer8$137
Sunovion Pharmaceuticals Inc.9$129
Biohaven Pharmaceutical Holding Company Ltd.5$106
Adlon Therapeutics L.p.6$101
Eisai Inc.5$99
Lundbeck LLC5$97
Upsher-smith Laboratories LLC5$95
IBSA Pharma Inc.6$94
Bausch Health US, LLC6$85
Teva Pharmaceuticals USA, Inc.6$78
Tris Pharma Inc4$75
Johnson & Johnson5$71
Sumitomo Pharma America, Inc.4$71
Idorsia Pharmaceuticals US Inc4$69
Jazz Pharmaceuticals Inc.4$66
VBI Vaccine (delaware) Inc.4$65
Genentech USA, Inc.4$62
Radius Health, Inc.3$56
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC4$56
Sanofi-aventis U.S. LLC3$55
Kowa Pharmaceuticals America, Inc.4$54
Inspire Medical Systems, Inc.2$51
Vanda Pharmaceuticals Inc.2$50
Avanir Pharmaceuticals, Inc.3$50
Esperion Therapeutics, Inc.3$49
Novartis3$45
Halozyme Inc3$43
Supernus Pharmaceuticals, Inc.2$41
Althera Pharmaceuticals LLC3$39
Dexcom, Inc.2$38
Phathom Pharmaceuticals, Inc.2$33
Shield Therapeutics Inc1$26
Mayne Pharma Commercial LLC1$25
Seqirus USA Inc1$21
Recordati_rare_diseases_inc.1$20
Exact Sciences1$18
Cranial Technologies, Inc1$18
E.r. Squibb & Sons, L.L.C.1$16
Clarus Therapeutics Inc.1$16
Hologic Sales And Service, LLC1$16
Ironshore Pharmaceuticals Inc.1$15
Medtronic1$14
Optos, Inc.1$14
AMAG Pharmaceuticals, Inc.1$12
Circassia Inc.1$12

How this compares

$11,928 in reported general payments places this provider in the 90th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$143,052
Medicare patients
355
Services billed
2,577

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide156$202,124
MounjaroTirzepatide93$108,754
EliquisApixaban65$85,934
JardianceEmpagliflozin59$68,753
ProliaDenosumab37$63,711
VascepaIcosapent Ethyl64$39,772
JanumetSitagliptin Phos/Metformin Hcl33$26,656
RybelsusSemaglutide15$26,315
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog17$18,662
MyrbetriqMirabegron27$17,283
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$16,890
FarxigaDapagliflozin Propanediol17$16,296
JanuviaSitagliptin Phosphate15$15,416
XareltoRivaroxaban15$15,014
Icosapent Ethyl35$12,552

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$1,027$228,439171 claims
Lilly USA, LLCMounjaro$740$108,75493 claims
PfizerEliquis$537$85,93465 claims
Boehringer IngelheimJardiance$779$68,75359 claims
AmgenProlia$805$63,71137 claims
MerckJanumet, Januvia$318$42,07148 claims
AstraZenecaFarxiga, Symbicort$1,034$20,84931 claims
Astellas Pharma US IncMyrbetriq$475$17,28327 claims
GSKTrelegy Ellipta$295$16,89017 claims
Johnson & JohnsonXarelto$71$15,01415 claims
AbbVieLinzess, Synthroid$1,660$12,37576 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Fort Worth

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →